Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lizette Perez-Perez"'
Autor:
Kyle Rosenke, Michael A. Jarvis, Friederike Feldmann, Benjamin Schwarz, Atsushi Okumura, Jamie Lovaglio, Greg Saturday, Patrick W. Hanley, Kimberly Meade-White, Brandi N. Williamson, Frederick Hansen, Lizette Perez-Perez, Shanna Leventhal, Tsing-Lee Tang-Huau, Julie Callison, Elaine Haddock, Kaitlin A. Stromberg, Dana Scott, Graham Sewell, Catharine M. Bosio, David Hawman, Emmie de Wit, Heinz Feldmann
Publikováno v:
JCI Insight, Vol 5, Iss 23 (2020)
We remain largely without effective prophylactic/therapeutic interventions for COVID-19. Although many human COVID-19 clinical trials are ongoing, there remains a deficiency of supportive preclinical drug efficacy studies to help guide decisions. Her
Externí odkaz:
https://doaj.org/article/28b738a56bae42afa6e041613cef0ac9
Autor:
Stephanie Banakis, Tara N. Palmore, Allison Roder, Alexandra Muchegian, Matt Chung, Sanchita Das, Wei Wang, Christopher Mederos, James N. Kochenderfer, Lizette Perez-Perez, Elodie Ghedin, Jung-Ho Youn, Emmie de Wit, Jennifer N. Brudno, Veronique Nussenblatt
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 2
The Journal of Infectious Diseases
article-version (status) pre
article-version (number) 2
The Journal of Infectious Diseases
Background: B-cell depleting therapies may lead to protracted disease and prolonged viral shedding in individuals infected with SARS-CoV-2. Viral persistence in the setting of immunosuppression raises concern for viral evolution. Methods: Amplificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d913c8108a8857762c454a7c99d473fe
https://doi.org/10.1101/2021.10.02.21264267
https://doi.org/10.1101/2021.10.02.21264267
Autor:
Patrick W. Hanley, Jamie Lovaglio, Julie Callison, Brandi N. Williamson, Dana P. Scott, Emmie de Wit, Frederick Hansen, Graham Sewell, Greg Saturday, Elaine Haddock, Kimberly Meade-White, Michael A. Jarvis, Kyle Rosenke, Atsushi Okumura, Heinz Feldmann, Friederike Feldmann, Lizette Perez-Perez, Shanna Leventhal, David W Hawman, Kaitlin A. Stromberg, Tsing Lee Tang-Huau, Catharine M. Bosio, Benjamin Schwarz
Publikováno v:
JCI Insight, Vol 5, Iss 23 (2020)
JCI Insight
JCI Insight
We remain largely without effective prophylactic/therapeutic interventions for COVID-19. Although many human COVID-19 clinical trials are ongoing, there remains a deficiency of supportive preclinical drug efficacy studies to help guide decisions. Her
Autor:
Patrick W. Hanley, Jamie Lovaglio, Kimberly Meade-White, Tsing-Lee Tang-Huau, Lizette Perez-Perez, Catharine M. Bosio, Julie Callison, Brandi N. Williamson, Benjamin Schwarz, Greg Saturday, Kyle Rosenke, Michael A. Jarvis, Friederike Feldmann, Martha Nason, Frederick Hansen, Emmie de Wit, Dana P. Scott, Graham Sewell, Shanna Leventhal, David W Hawman, Elaine Haddock, Heinz Feldmann, Atsushi Okumura
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
We remain largely without effective prophylactic/therapeutic interventions for COVID-19. Although many human clinical trials are ongoing, there remains a deficiency of supportive preclinical drug efficacy studies. Here we assessed the prophylactic/th